Takeda to buy Shire for $62 billion

Takeda Pharmaceutical Co. Ltd. has agreed to acquire Shire plc for $62 billion. The companies announced the preliminary deal on Tuesday morning following weeks of back-and-forth negotiations. The talks played out in public thanks to a quirk of U.K. securities laws, which require listed companies like Shire to disclose takeover offers. The deal, which is subject to approval f rom shareholders, would give Shire's stockholders part cash plus Takeda stock. After the acquisition, Shire shareholders would…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news